Caption Management’s Wave Life Sciences WVE Stock Holding History

Caption Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.3K	Sell	9,000 -34,200	-79%	-$227K	﹤0.01%	1548
2026 Q1	$313K	Buy	+43,200	New	+$563K	﹤0.01%	1293
2025 Q4	–	Sell	-12,000	Closed	-$122K	–	2126
2025 Q3	$87.8K	Buy	+12,000	New	+$97.1K	﹤0.01%	1541
2025 Q2	–	Sell	-43,501	Closed	-$287K	–	1960
2025 Q1	$351K	Buy	43,501 +4,401	+11%	+$48.1K	﹤0.01%	1179
2024 Q4	$484K	Buy	+39,100	New	+$522K	﹤0.01%	1114
2021 Q2	–	Sell	-87,957	Closed	-$493K	–	1611
2021 Q1	$493K	Buy	+87,957	New	+$845K	0.01%	809
2020 Q1	–	Sell	-36,000	Closed	-$289K	–	1112
2019 Q4	$289K	Sell	36,000 -44,000	-55%	-$1.08M	0.01%	691
2019 Q3	$1.64M	Sell	80,000 -600	-0.7%	-$13.8K	0.09%	280
2019 Q2	$2.1M	Buy	+80,600	New	+$2.26M	0.11%	234

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Caption Management's WVE Position: Q2 2026 in Review

Caption Management reduced its Wave Life Sciences (WVE) stake by 79% in Q2 2026, selling an estimated $227K and leaving 9,000 shares worth $52.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Caption Management first reported a position in WVE in Q2 2019 and has held it in 9 quarters since. The position peaked at $2.1M in Q2 2019. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Caption Management held 9,000 shares of Wave Life Sciences worth $52.3K as of Q2 2026.
Caption Management sold 34,200 Wave Life Sciences shares in Q2 2026, an estimated $227K.
Wave Life Sciences made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1548 holding.
Caption Management first reported a position in Wave Life Sciences in Q2 2019 and has held it in 9 quarters since.
Caption Management's Wave Life Sciences position peaked at $2.1M in Q2 2019.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.